This retrospective study evaluated the safety and efficacy of post-operative blood salvage and retransfusion in 430 patients undergoing total hip arthroplasty and 530 patients undergoing total knee arthroplasty. Volumes of autologous blood retransfused (mean ± SD) were 525 ± 75 and 660 ± 95 ml in the hip and knee replacement groups, respectively. Overall, 230 patients (24%) also required allogeneic blood transfusion. In a subgroup of 150 randomly selected patients, the values of free haemoglobin in the allogeneic, autologous and patients' blood at the time of surgery were 0.568 ± 0.112, 0.272 ± 0.067 and 0.032 ± 0.011 g/l, respectively. On the first and third post-operative days, the levels in patients' blood were 0.092 ± 0.039 and 0.057 ± 0.028 g/l, respectively. There were no major complications; transient chills and fever were reported in 99 (10.3%) and 115 patients (12.0%), respectively. In conclusion, post-operative blood salvage and retransfusion is a safe way to reduce the need for allogeneic blood transfusion in patients undergoing elective orthopaedic surgery.
Introduction
Total hip and knee arthroplasties are usually accompanied by considerable blood loss requiring post-operative blood transfusion. Allogeneic (homologous) blood transfusion is associated with several well-recognized risks and complications, such as allergic reactions, transmission of infectious agents and immunomodulatory effects. 1, 2 Concerns about the transmission of infectious diseases, such as hepatitis, acquired immunodeficiency syndrome and pyogenic infections, have revolutionized the approach of many physicians to allogeneic blood transfusion. 1, 2 One of the main goals of blood management for patients undergoing total joint replacement is to reduce the need for transfusion with allogeneic blood. Orthopaedic surgeons have been at the forefront of introducing procedures to avoid allogeneic transfusions, including pre-donation programmes, peri-operative blood salvage techniques such as acute normovolaemic haemodilution and intra-operative cell V Athanasoulias, AF Mavrogenis, CV Sdrenias et al.
Post-operative blood salvage and retransfusion salvage, acceptance of lower haemoglobin and haematocrit levels, and post-operative blood salvage and autotransfusion. 1 -4 This retrospective study of case records evaluated the safety and efficacy of postoperative blood salvage and retransfusion in patients undergoing primary total hip or knee arthroplasty.
Patients and methods PATIENTS
The medical records were reviewed for patients who had undergone total hip or total knee arthroplasty for either primary degenerative or rheumatoid hip or knee arthritis with post-operative blood salvage and retransfusion. All operations were performed using spinal and/or epidural anaesthesia and all patients received anticoagulation prophylaxis using low molecular weight heparin.
POST-OPERATIVE BLOOD SALVAGE
For all patients, the Ortho Pas™ (Eurosets Medical Devices, Medolla, Italy) autotransfusion apparatus was used ( Fig. 1A ). This is a sterile, closed system consisting of a disposable salvaged blood collection kit (700 ml total volume capacity), which does not contain anticoagulant agents, and a multi-use micro-aspiration unit (vacuum generator) with rechargeable battery. The use of vacuum aspiration of the blood facilitates haemostasis and minimizes the risk of haematoma formation. The vacuum generator allows aspiration at pre-selected values between −10 and −95 cmH 2 O. In all patients the device was set to a negative pressure of −40 to −70 cmH 2 O.
The post-operative blood salvage apparatus is connected to the wound drain using a sterile technique. Drained blood is filtered through a 120 µm macrofilter and then through a 40 µm microfilter before being retransfused into the patient ( Fig. 1B -1E ). Effective filtering is important since any clots or microclots that form during blood collection must be removed to prevent pulmonary microembolism by microaggregates in the patient's circulation.
RETRANSFUSION AND ALLOGENEIC TRANSFUSION
The blood retransfusion rate was approximately 200 -300 ml/h. To avoid adverse reactions from the retransfusion of salvaged blood, retransfusion was performed once 250 ml of blood had accumulated in the collection unit up to a maximum of 1500 ml within the first 5 h after surgery. Thereafter, the apparatus was disconnected and left in place to serve as a regular wound drain.
Allogeneic blood was transfused to correct hypovolaemia, symptomatic anaemia with vertigo, dizziness, postural hypotension, headache, insomnia, confusion, tachycardia, angina or dyspnoea, or when the haemoglobin concentration decreased to < 9 g/dl because of increased intra-operative or continued post-operative blood loss after the end of the retransfusion.
EVALUATION OF TRANSFUSION
The volume of post-operative autologous blood retransfusion, the volume of allogeneic transfusion, haematocrit, haemoglobin and total bilirubin values pre-operatively and on the first and third post-operative days, and any adverse effects attributed to the retransfusion of autologous blood were recorded for each patient. In addition, the levels of free haemoglobin in the transfused blood (salvaged and allogeneic) and in the patient's blood were calculated pre-operatively and at 6 and 24 h post-operatively in randomly selected patients.
To evaluate the effect of retransfusion on haemostasis and the blood coagulation system, the platelet count, prothrombin V Athanasoulias, AF Mavrogenis, CV Sdrenias et al.
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DATA ANALYSIS
Results are given as the mean ± SD.
Results
The medical records from 430 patients who underwent a total hip arthroplasty and 530 patients who underwent a total knee arthroplasty with post-operative blood salvage and retransfusion were reviewed. In the total hip arthroplasty group, there were 140 men with a mean age of 68.3 years (range 65 -92 years) and 290 women with a mean age of 69.8 years (range 65 -92 years).
In the total knee arthroplasty group, there were 100 men with a mean age of 70.5 years (range 65 -85 years) and 430 women with a mean age of 67.5 years (range 65 -82 years).
The volume of autologous blood retransfused was 525 ± 75 ml in the total hip replacement group and 660 ± 95 ml in the total knee replacement group. Overall, 230 (24%) patients also required allogeneic blood transfusion; 173 (18%) patients received 1 unit of allogeneic blood and 57 (6%) patients received 2 units.
Pre-and post-operative haematocrit, haemoglobin and total bilirubin values are given in Table 1 . Platelet counts ranged from 279 000 ± 45 000 per mm 3 pre-operatively to 199 000 ± 35 000 per mm 3 on the third post-operative day. There were no significant changes in the activated partial thromboplastin time or international normalized ratio.
Assessments of free haemoglobin levels in transfused blood were performed in 150 randomly selected patients. The free haemoglobin levels in allogeneic, autologous and patients' blood pre-operatively were 0.568 ± 0.112, 0.272 ± 0.067 and 0.032 ± 0.011 g/l, V Athanasoulias, AF Mavrogenis, CV Sdrenias et al.
Post-operative blood salvage and retransfusion respectively. On the first and third postoperative days, the free haemoglobin levels in patients' blood were 0.092 ± 0.039 and 0.057 ± 0.028 g/l, respectively. Clinical and laboratory examinations including routine blood chemistry, coagulation status and urinalysis showed no evidence of complications such as fat embolism, coagulopathy, renal failure, acute haemolytic reactions, jaundice or sepsis. Transient chills and fever of approximately 38°C were reported in 99 (10.3%) and 115 patients (12.0%), respectively. All of these patients responded quickly to intravenous fluids, administration of antipyretic drugs and discontinuation of the transfusion. There were no serious complications such as haematomas and seromas requiring further surgery.
Discussion
The number of allogeneic transfusions has decreased in recent years due to the risk of transmitting human immunodeficiency virus, hepatitis or cytomegalovirus to the recipients. Although blood can be tested, the donor may be in the 'window period' for determining infectivity. 3, 5 Allogeneic transfusions have also been associated with immunosuppression or immunomodulation of recipients. 3, 6, 7 It has been reported that renal transplant patients had lower allograft rejection rates and improved allograft survival times if they received transfusions of allogeneic blood before receiving their allograft. 3, 6 Moreover, cell-mediated immunity, macrophage migration and natural killer cell activity have been shown to decrease after allogeneic blood transfusion. 7 Interestingly, allogeneic blood transfusions have also been implicated in causing postoperative infections. Murphy et al. 5 
and
Triulzi et al. 7 demonstrated the predictive effect of allogeneic blood transfusions in post-operative infections: there was a significant increase in post-operative infection rates in patients who received an allogeneic blood transfusion during or after total hip or spine surgery compared with those who did not. Agarwal et al. 8 reported that patients who had suffered from trauma had a higher incidence of infection after receiving a transfusion when controlling for variables such as age, gender and mechanism of injury. In addition, Koval et al. 9 reported that patients who had hip surgery to repair a fracture and received an allogeneic blood transfusion had a significantly higher incidence of infection when compared with patients who did not receive an allogeneic transfusion.
A number of methods exist for decreasing transfusion requirements in the peri-operative period. These include autologous blood pre-donation, acute normovolaemic haemodilution, intra-operative cell salvage, post-operative salvage and autologous 3,4,10 -13 Pre-donation of autologous blood before the surgical operation is very effective in decreasing the requirements for allogeneic transfusion, with a low complication rate and a low incidence of reactions compared with allogeneic blood transfusion. 3, 14 An additional benefit is the accelerated erythropoiesis experienced by patients who undergo pre-donation. 15, 16 However, preoperative autologous blood donation is far from cost-effective. 17 Only a proportion of the pre-donated blood is transfused, and transfusion of allogeneic blood is not completely prevented. 18 In addition, predonation of blood may lead to pre-and postoperative immunosuppression, 19 and not all patients are suitable for pre-donation. 15 Acute normovolaemic haemodilution involves the rapid withdrawal of the patient's blood while maintaining the intravascular volume by reinfusion of colloid or crystalloid. 1, 3, 4 With this method, patients are maintained in a normovolaemic but relatively anaemic condition. Thus, intraoperatively a patient loses blood at a lower haematocrit level and at the conclusion of the operation the patient's blood that was initially withdrawn can be retransfused. Geriatric patients having a total hip or knee replacement may not tolerate haemodilution because of coronary artery disease. 20 Moreover, haemodilution should not be combined with hypotensive anaesthetic techniques. 1, 3, 4 In patients having major orthopaedic surgery, such as total hip or knee arthroplasty, peri-operative blood salvage is extremely useful because of the significant post-operative blood loss of > 250 ml in the first few hours and the accompanying decrease in haematocrit values, which necessitates allogeneic transfusion. 4,5,13,21 -23 Borghi et al. 24 reported that red cell predisposition and combined intra-and post-operative blood salvage is an effective technique for avoiding the use of allogeneic red cell transfusion. Friederichs et al. 12 reported a significant difference in the need for allogeneic transfusion in addition to retransfusion of salvaged blood in patients with a pre-operative haematocrit > 37% (1.2%) compared with those with a pre-operative haematocrit ≤ 37% (22%). In the present study, the patients had a pre-operative haematocrit of 38.7 ± 1.9%. Following the use of post-operative blood salvage and retransfusion, the need for allogeneic blood transfusion was low: 18 and 6% of the patients received 1 and 2 units of allogeneic blood, respectively.
Concerns with retransfusion of postoperative salvaged blood include renal failure from free haemoglobin, retransfusion of anticoagulants, adult respiratory distress syndrome, disseminated intravascular coagulation, complement activation and adverse reactions from bone debris and methylmethacrylate monomers. 3,10 -12,25 -30 It is therefore essential that filtered autologous blood is acceptable for retransfusion. 1 -4,27,31 Because of the presence of bone, fat, debris, anticoagulant and haemolysed red blood cells, it is highly recommended that blood salvaged during orthopaedic procedures be washed rigorously. Hand et al. 27 reported that unwashed salvaged blood showed low levels of methylmethacrylate in total knee arthroplasty patients having autologous blood retransfusion. In their study, systemic blood showed no evidence of methylmethacrylate monomer either before or 5 min after retransfusion. 27 A thorough wash of the surgical wound with sterile physiological solution and adequate closure of the fascia and subcutaneous tissue V Athanasoulias, AF Mavrogenis, CV Sdrenias et al.
Post-operative blood salvage and retransfusion are necessary to decrease the debris concentration in salvaged blood. Moreover, intra-operative cell salvage is contraindicated in cases with infection or malignancy at the operative site. 1 -4,31 In the present study the free haemoglobin values due to haemolysis did not exceed 0.5 g/l. Such levels do not produce haemoglobinuria in patients who have a normal level of haptoglobin, an α 2 globulin that binds plasma haemoglobin to prevent its renal excretion. 25 In a study by Faris et al. 25 the highest level of free haemoglobin was 0.5 g/l. In their study, the elevated levels of plasma haemoglobin were related to the supernatant haemoglobin in the autologous and allogeneic blood, and to the haemolysis occurring during blood collection. In the present study, free haemoglobin levels were increased after blood transfusion, but gradually decreased in the early postoperative period.
Dalen et al. 10 reported reduced leucocyte and platelet counts in autologous blood from wound drainage. The pH after 5 h had fallen to 7.2, causing slight erythrocyte swelling; however, the maximum erythrocyte haemolysis after 24 h of incubation was < 1%. 10 Analysis of blood salvaged postoperatively has shown that the coagulation parameters are changed significantly. Infusion of salvaged blood, however, did not cause any significant changes in prothrombin time, partial thromboplastin time, fibrinogen or antithrombin in patients' plasma. 10, 15, 26 Groh et al. 26 reported that the post-operative values of prothrombin and partial thromboplastin times, urea and creatinine in patients who received postoperative autologous blood transfusion were comparable to the pre-operative values. In addition, blood cultures taken randomly 14 days post-operatively in patients who had received autologous blood transfusion were negative. 26 Han and Shin 11 reported no complications such as air embolism, coagulopathy, renal failure or sepsis in 135 patients with total knee and total hip arthroplasty who had post-operative autologous blood retransfusion from wound drainage. Jensen et al. 15 reported that autologous blood collected and retransfused within 6 h post-operatively from 10 patients after total knee arthroplasty had significantly increased values of histamine, eosinophil cationic protein, eosinophilic protein X, myeloperoxidase, plasminogen activator inhibitor type 1 and activated complement factor C3 immediately before and at the end of retransfusion; 15 moreover, the autologous blood was defibrinated. However, retransfusion of the salvaged blood did not change the coagulation status of the patients. 15 The commonest adverse reaction to the retransfusion of salvaged blood is an increase in temperature, probably due to a cytokine-mediated inflammatory reaction. 28 Dalen et al. 28 reported that retransfusion of filtered drained blood within the first 8 h post-operatively after total knee arthroplasty did not seem to cause an additional increase in temperature above that due to spontaneous recovery after post-operative hypothermia and surgical trauma. Moreover, this reaction can also be observed in patients receiving allogeneic transfusion, further supporting the safety of blood salvage by this method. 32 In the present study, the only major complications that could be attributed to post-operative blood salvage and retransfusion were transient shaking chills and fever. Clinical manifestations of renal failure from free haemoglobin, air embolism, adult respiratory distress syndrome, coagulopathy or disseminated intravascular coagulation were not observed; laboratory V Athanasoulias, AF Mavrogenis, CV Sdrenias et al.
Post-operative blood salvage and retransfusion analyses, including blood chemistry, coagulation status and urinalysis, were within normal limits. The cost of post-operative blood salvage has been reported to be roughly equivalent to the cost of pre-donating 2 units of blood. 12, 13, 21 If the cost per unit of allogeneic banked blood, the cost of pre-donation, the average waste of 45 -50% of the pre-donated blood 12, 18, 26, 32 and the cost of the hospital stay 22 are included, post-operative blood salvage and retransfusion is shown to be a more cost-effective procedure for primary total hip and total knee arthroplasty. 12,17 -19,26 In conclusion, many methods exist to decrease the need for allogeneic transfusion. Although autotransfusion systems can be improved with respect to blood quality, filtered salvaged blood should be considered acceptable for retransfusion. The results of the present study suggest that postoperative blood salvage and retransfusion is a safe way to reduce the need for allogeneic blood transfusion in elective orthopaedic patients undergoing total hip or knee arthroplasty, with minor complications. Ample surgical wound washing, firm closure of fascia and retransfusion within 6 h after the commencement of postoperative blood salvage are recommended to minimize the potential for haemolytic or febrile reactions.
